Clinical experience with nanoparticle albumin-bound paclitaxel, a novel taxane anticancer agent, and management of adverse events in females with breast cancer

Category Primary study
JournalOncology Letters
Year 2015
This article has no abstract
Epistemonikos ID: 6ea630e48b7988e2b9a50bb3236d07ec90ae67ea
First added on: Feb 06, 2025